RenovoRx Inc.
1.38
0.06 (4.55%)
At close: Jan 15, 2025, 2:31 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue n/a 6.00K 9.00K n/a n/a
Gross Profit n/a -6.00K -9.00K n/a n/a
Operating Income -11.40M -9.95M -5.67M -3.20M -3.90M
Interest Income n/a 57.00K n/a 3.00K 63.00K
Pretax Income -10.23M -9.89M -6.32M -3.80M -3.84M
Net Income -10.23M -9.77M -7.10M -4.38M -3.78M
Selling & General & Admin 5.73M 5.65M 2.63M 818.00K 899.00K
Research & Development 5.67M 4.30M 3.04M 2.39M 3.00M
Other Expenses n/a 61.00K 119.00K -7.00K 2.00K
Operating Expenses 11.40M 9.95M 5.67M 3.20M 3.90M
Interest Expense 108.00K 57.00K 834.00K 590.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 11.40M 9.95M 5.67M 3.20M 3.90M
Income Tax n/a -118.00K 772.00K 587.00K -63.00K
Shares Outstanding (Basic) 10.29M 9.05M 8.93M 8.66M 8.66M
Shares Outstanding (Diluted) 10.29M 9.05M 8.93M 8.66M 8.66M
EPS (Basic) -0.99 -1.08 -0.79 -0.51 -0.44
EPS (Diluted) -0.99 -1.08 -0.79 -0.51 -0.44
EBITDA -11.39M -9.94M -5.66M n/a n/a
Depreciation & Amortization 6.00K 6.00K 9.00K 3.20M 3.90M